BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Asai A, Tsuchimoto Y, Ohama H, Fukunishi S, Tsuda Y, Kobayashi M, Higuchi K, Suzuki F. Host antitumor resistance improved by the macrophage polarization in a chimera model of patients with HCC. Oncoimmunology 2017;6:e1299301. [PMID: 28507807 DOI: 10.1080/2162402X.2017.1299301] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Guo Y, Tsai H, Zhang L, Zhu H. Mitochondrial DNA on Tumor-Associated Macrophages Polarization and Immunity. Cancers 2022;14:1452. [DOI: 10.3390/cancers14061452] [Reference Citation Analysis]
2 Lü W, Liu Y, Yang Y, Liu Z, Zhao K, Lu J, Lei G, Wang Y, Cai L, Sun R. Effect of naturally derived surgical hemostatic materials on the proliferation of A549 human lung adenocarcinoma cells. Materials Today Bio 2022;14:100233. [DOI: 10.1016/j.mtbio.2022.100233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Bresnahan E, Lindblad KE, Ruiz de Galarreta M, Lujambio A. Mouse Models of Oncoimmunology in Hepatocellular Carcinoma. Clin Cancer Res 2020;26:5276-86. [PMID: 32327473 DOI: 10.1158/1078-0432.CCR-19-2923] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
4 Asai A, Yasuoka H, Matsui M, Tsuchimoto Y, Fukunishi S, Higuchi K. Programmed Death 1 Ligand Expression in the Monocytes of Patients with Hepatocellular Carcinoma Depends on Tumor Progression. Cancers (Basel) 2020;12:E2286. [PMID: 32824016 DOI: 10.3390/cancers12082286] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Tian MX, Liu WR, Wang H, Zhou YF, Jin L, Jiang XF, Tao CY, Tang Z, Zhou PY, Fang Y, Qu WF, Ding ZB, Peng YF, Dai Z, Qiu SJ, Zhou J, Lau WY, Fan J, Shi YH. Tissue-infiltrating lymphocytes signature predicts survival in patients with early/intermediate stage hepatocellular carcinoma. BMC Med 2019;17:106. [PMID: 31164128 DOI: 10.1186/s12916-019-1341-6] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
6 Liu Y, Ji X, Kang N, Zhou J, Liang X, Li J, Han T, Zhao C, Yang T. Tumor necrosis factor α inhibition overcomes immunosuppressive M2b macrophage-induced bevacizumab resistance in triple-negative breast cancer. Cell Death Dis 2020;11:993. [PMID: 33214550 DOI: 10.1038/s41419-020-03161-x] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
7 Liu WR, Tian MX, Tang Z, Fang Y, Zhou YF, Song SS, Jiang XF, Wang H, Tao CY, Zhou PY, Qu WF, Ding ZB, Peng YF, Zhou J, Fan J, Shi YH. Nine-factor-based immunohistochemistry classifier predicts recurrence for early-stage hepatocellular carcinoma after curative resection. Br J Cancer 2020;123:92-100. [PMID: 32376890 DOI: 10.1038/s41416-020-0864-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Yang R, Liao Y, Wang L, He P, Hu Y, Yuan D, Wu Z, Sun X. Exosomes Derived From M2b Macrophages Attenuate DSS-Induced Colitis. Front Immunol 2019;10:2346. [PMID: 31749791 DOI: 10.3389/fimmu.2019.02346] [Cited by in Crossref: 30] [Cited by in F6Publishing: 27] [Article Influence: 10.0] [Reference Citation Analysis]
9 Hourani T, Holden JA, Li W, Lenzo JC, Hadjigol S, O'Brien-Simpson NM. Tumor Associated Macrophages: Origin, Recruitment, Phenotypic Diversity, and Targeting. Front Oncol 2021;11:788365. [PMID: 34988021 DOI: 10.3389/fonc.2021.788365] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 6.0] [Reference Citation Analysis]
10 Camelliti S, Le Noci V, Bianchi F, Storti C, Arnaboldi F, Cataldo A, Indino S, Jachetti E, Figini M, Colombo MP, Balsari A, Gagliano N, Tagliabue E, Sfondrini L, Sommariva M. Macrophages Impair TLR9 Agonist Antitumor Activity through Interacting with the Anti-PD-1 Antibody Fc Domain. Cancers (Basel) 2021;13:4081. [PMID: 34439233 DOI: 10.3390/cancers13164081] [Reference Citation Analysis]
11 Bianchini R, Roth-Walter F, Ohradanova-Repic A, Flicker S, Hufnagl K, Fischer MB, Stockinger H, Jensen-Jarolim E. IgG4 drives M2a macrophages to a regulatory M2b-like phenotype: potential implication in immune tolerance. Allergy 2019;74:483-94. [PMID: 30338531 DOI: 10.1111/all.13635] [Cited by in Crossref: 34] [Cited by in F6Publishing: 30] [Article Influence: 11.3] [Reference Citation Analysis]
12 Yasuoka H, Asai A, Ohama H, Tsuchimoto Y, Fukunishi S, Higuchi K. Increased both PD-L1 and PD-L2 expressions on monocytes of patients with hepatocellular carcinoma was associated with a poor prognosis. Sci Rep 2020;10:10377. [PMID: 32587357 DOI: 10.1038/s41598-020-67497-2] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 5.0] [Reference Citation Analysis]
13 Wang LX, Zhang SX, Wu HJ, Rong XL, Guo J. M2b macrophage polarization and its roles in diseases. J Leukoc Biol 2019;106:345-58. [PMID: 30576000 DOI: 10.1002/JLB.3RU1018-378RR] [Cited by in Crossref: 120] [Cited by in F6Publishing: 82] [Article Influence: 30.0] [Reference Citation Analysis]
14 Zhu C, Su Y, Liu L, Wang S, Liu Y, Wu J. Circular RNA hsa_circ_0004277 Stimulates Malignant Phenotype of Hepatocellular Carcinoma and Epithelial-Mesenchymal Transition of Peripheral Cells. Front Cell Dev Biol 2020;8:585565. [PMID: 33511111 DOI: 10.3389/fcell.2020.585565] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]